Apparently some testing was conducted; it's mentioned on p. 49 in the MHRA assesment report,
albeit not in a lot of detail:
Laboratory testing was only conducted in a subgroup of subjects up to 28 days after each
dose. The incidence of decreases in white blood cells, neutrophils, and platelets was slightly
higher in the AZD1222 group compared with control. ...